Portefeuille de l'ETF XBI (NYSE) | MetaTrader

Afficher le graphique complet Full chart

Aperçu Toutes les participations Heatmap

Principaux titres en portefeuille Market Value Shares Weight %

F

FOLD Amicus Therapeutics Inc 117.0 M 8.2 M 1.5%

PRAX Praxis Precision Medicines Inc 109.2 M 370.4 K 1.4%

TVTX Travere Therapeutics Inc 107.7 M 2.8 M 1.4%

BMRN BioMarin Pharmaceutical Inc 107.2 M 1.8 M 1.4%

HALO Halozyme Therapeutics Inc 104.1 M 1.5 M 1.3%

ROIV Roivant Sciences Ltd 103.9 M 4.8 M 1.3%

EXEL Exelixis Inc 103.4 M 2.4 M 1.3%

REGN Regeneron Pharmaceuticals Inc 103.0 M 133.4 K 1.3%

PCVX Vaxcyte Inc 102.8 M 2.2 M 1.3%

MDGL Madrigal Pharmaceuticals Inc 102.1 M 175.4 K 1.3%

CYTK Cytokinetics Inc 102.1 M 1.6 M 1.3%

BBIO Bridgebio Pharma Inc 102.0 M 1.3 M 1.3%

AMGN Amgen Inc 100.6 M 307.3 K 1.3%

INCY Incyte Corp 100.6 M 1.0 M 1.3%

KRYS Krystal Biotech Inc 99.7 M 404.2 K 1.3%

PTCT PTC Therapeutics Inc 99.3 M 1.3 M 1.3%

RVMD Revolution Medicines Inc 99.1 M 1.2 M 1.3%

RYTM Rhythm Pharmaceuticals Inc 99.0 M 925.0 K 1.3%

VRTX Vertex Pharmaceuticals Inc 98.8 M 217.9 K 1.3%

MRNA Moderna Inc 98.4 M 3.3 M 1.3%

1
2
3
4
5
6
7
8

Nouvelles

First Quarter Earnings: Sharpening Sector Divergence

Is State Street SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now?

3 Reasons To Stick With Growth Stocks In Rotating Markets

Seeking Innovation Beyond Tech? Insight On Healthcare Stocks

Biotech Investors Are Tuning Out the MAHA Chaos

Makary's Successor Faces Tough Task Managing FDA Amid Budget Cuts

Maravai LifeSciences: Better Earnings Drive Gains That Ought To Be Sustainable (MRVI)

Jefferies abaisse la note de Tango Therapeutics en raison de la valorisation

FDA Commissioner Marty Makary Expected To Resign, Ending Turbulent Stint

Why I Now Favor A Barbell Model Over Ray Dalio’s All-Weather Portfolio (SPY)

La vente à découvert d’Intellia progresse le plus parmi les biotechs

What's The Dominant Trend In Earnings: AI Or Geopolitics?